🩺🎗️ Cardio-Oncology Insight: Not Every Breast Cancer Survivor Needs a Cardiologist

As breast cancer survivorship grows, understanding who truly benefits from long-term cardiac follow-up becomes essential. An important editorial in JAMA Oncology underscores a key principle: risk-stratified care, not reflex surveillance.

👩‍⚕️🔍 Age and traditional cardiovascular risk factors outweigh treatment exposure (including anthracyclines and ERBB2 therapy) in driving late heart failure and cardiomyopathy risk among survivors .

🏥💡 Most survivors can be safely followed by primary care clinicians focused on:

• Controlling blood pressure, diabetes, lipids

• Encouraging physical activity & healthy weight

• Monitoring symptoms and functional status

❤️📊 Select high-risk patients — older age, multiple CV risk factors, or treatment-related dysfunction — benefit most from targeted cardio-oncology evaluation.

This editorial reminds us that precision survivorship means personalizing cardiac follow-up, emphasizing prevention, equity, and collaboration between oncology, cardiology, and primary care.

🌱 Goal: Survivors who not only live longer — but live well.

#CardioOncology #BreastCancer #Survivorship #HeartFailurePrevention #PrecisionMedicine #PrimaryCare #JAMAOncology #CancerCare #CardioOnc #PopulationHealth #AcademicMedicine